12/23/2025
💊 Why this approval matters...
Oral semaglutide has been used for years in the treatment of type 2 diabetes but is now finally approved specifically for weight management.
What do the studies show?
Patients taking oral semaglutide lost about 15–17% of their body weight, compared to only 2–3% with placebo.
Why this matters:
• Oral option — no injections
• Targets appetite and metabolic health
• Adds flexibility to medical weight loss treatment
We are hopeful that this option will be available beginning as early as January, offering you a new way to start the year strong with more options to choose from for your weight loss journey.
We believe that the right treatment depends on the individual, which is why we offer an initial consultation visit with an expert. You can book this appointment on our website anytime you are ready.
We look forward to discussing the options with you!